Invera Wealth Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$960K Buy
3,666
+222
+6% +$58.5K 0.5% 56
2026
Q2
$761K Sell
3,444
-48
-1% -$13.3K 0.41% 66
2026
Q1
$1.03M Sell
3,492
-46
-1% -$13.7K 0.66% 47
2025
Q4
$966K Sell
3,538
-120
-3% -$32.6K 0.61% 50
2025
Q3
$988K Sell
3,658
-27
-0.7% -$7.35K 0.61% 54
2025
Q2
$1.02M Sell
3,685
-61
-2% -$16.6K 0.66% 49
2025
Q1
$994K Sell
3,746
-147
-4% -$36.3K 0.64% 56
2024
Q4
$909K Buy
3,893
+20
+0.5% +$4.6K 0.9% 29
2024
Q3
$860K Buy
3,873
+88
+2% +$18.2K 0.85% 31
2024
Q2
$741K Buy
3,785
+125
+3% +$25.8K 0.76% 32
2024
Q1
$767K Sell
3,660
-77
-2% -$16.2K 0.65% 43
2023
Q4
$787K Buy
+3,737
New +$797K 0.49% 65

Other funds holding CME

Invera Wealth Advisors's CME Position: Q3 2026 in Review

Invera Wealth Advisors increased its CME Group (CME) stake by 6.4% in Q3 2026, buying an estimated $58.5K and bringing the position to 3,666 shares worth $960K. The position accounts for 0.5% of the portfolio, ranked #56.

Invera Wealth Advisors first reported a position in CME in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.03M in Q1 2026. 1,767 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Invera Wealth Advisors held 3,666 shares of CME Group worth $960K as of Q3 2026.
  • Invera Wealth Advisors bought 222 CME Group shares in Q3 2026, an estimated $58.5K.
  • CME Group made up 0.5% of Invera Wealth Advisors's portfolio in Q3 2026, its #56 holding.
  • Invera Wealth Advisors first reported a position in CME Group in Q4 2023 and has held it in 12 quarters since.
  • Invera Wealth Advisors's CME Group position peaked at $1.03M in Q1 2026.
  • 1,767 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Invera Wealth Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.